|
Volumn 16, Issue 7, 1998, Pages
|
Angiotensin II receptor blockade and end-organ protection: Pharmacological rationale and evidence
a a a |
Author keywords
ACE inhibitors; Angiotensin receptors; AT1 receptor antagonists; Congestive heart failure; Diabetes; End organ protection; Hypertension; Irbesartan; Left ventricular hypertrophy; Myocardial infarction; Renin angiotensin system; Vasculature
|
Indexed keywords
ANGIOTENSIN;
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN 2 RECEPTOR;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
RECEPTOR SUBTYPE;
SODIUM ION;
WATER;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR FUNCTION;
CELL PROLIFERATION;
CONFERENCE PAPER;
GLOMERULOSCLEROSIS;
GLOMERULUS FILTRATION;
HEART FAILURE;
HEART HYPERTROPHY;
HEART INFARCTION;
HEART MUSCLE CONTRACTILITY;
HOMEOSTASIS;
HUMAN;
HYPERTENSION;
KIDNEY TUBULE ABSORPTION;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
PROTEIN URINE LEVEL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
VASCULAR DISEASE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BLOOD PRESSURE;
BLOOD VESSELS;
CARDIOVASCULAR DISEASES;
HEART;
HUMANS;
KIDNEY TUBULES;
MYOCARDIAL CONTRACTION;
RECEPTORS, ANGIOTENSIN;
RENIN-ANGIOTENSIN SYSTEM;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0031720741
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (74)
|
References (15)
|